Chronic Conditions and Their Age of Onset Predict Health Trajectory in IBD

Medically reviewed by Carmen Pope, BPharm. Last updated on March 24, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, March 24, 2025 -- Among people with inflammatory bowel disease (IBD), conditions developed at or before age 60 years and their age of onset are important for predicting premature death, according to a study published online March 24 in CMAJ, the journal of the Canadian Medical Association.

Gemma Postill, from the University of Toronto, and colleagues examined premature death (age younger than 75 years) among people with IBD and identified patterns between multimorbidity and premature death among decedents with IBD using administrative health data for people with IBD who died between 2010 and 2020. Statistical and machine learning models were developed to predict premature death from the presence of 17 chronic conditions and patient age at diagnosis.

The researchers found that all models showed strong performance, with areas under the receiver operating curve (AUC) ranging from 0.81 to 0.95. The model that incorporated age at diagnosis for each chronic condition developed at or before 60 years was the best performing (AUC, 0.95). Young ages of diagnosis for mood disorder, other mental health disorders, osteoarthritis and other arthritis types, and hypertension, as well as male sex, were salient features for predicting premature death.

"Among decedents with IBD, machine learning models can accurately predict premature death associated with non-IBD comorbidities, with stronger performance for models trained on early-life conditions (age ≤60 years), suggesting these may be more important in determining one's health trajectory," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords